Alkermes Investigational Site — Washington D.C., District of Columbia

Alkermes Investigational Site is a clinical research site located in Washington D.C., District of Columbia, United States 20016.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

Alkermes Investigational Site has participated in 12 clinical trials with 1 currently active.

Therapeutic areas: Schizophrenia, Alcohol Use Disorder, Relapsing Remitting Multiple Sclerosis.

Sponsors: Alkermes, Inc., Biogen.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Alkermes Investigational Site?

Alkermes Investigational Site has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Alkermes Investigational Site conducted?

Alkermes Investigational Site has 12 clinical trials on record, with 1 currently active. Their work covers Schizophrenia, Alcohol Use Disorder, Relapsing Remitting Multiple Sclerosis.

Is Alkermes Investigational Site accredited by Crixeo Health?

Alkermes Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Alkermes Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.